• Open Access

Downregulation of HTPAP transcript variant 1 correlates with tumor metastasis and poor survival in patients with hepatocellular carcinoma

Authors

  • Chun Dai,

    1. Liver Cancer Institute & Zhongshan Hospital, Institutes of Biomedical Science, Fudan University, Shanghai, China; Key Laboratory of Carcinogenesis & Cancer Invasion, Ministry of Education, China
    Search for more papers by this author
    • Co-first authors.

  • Qiong-Zhu Dong,

    1. Liver Cancer Institute & Zhongshan Hospital, Institutes of Biomedical Science, Fudan University, Shanghai, China; Key Laboratory of Carcinogenesis & Cancer Invasion, Ministry of Education, China
    Search for more papers by this author
    • Co-first authors.

  • Ning Ren,

    1. Liver Cancer Institute & Zhongshan Hospital, Institutes of Biomedical Science, Fudan University, Shanghai, China; Key Laboratory of Carcinogenesis & Cancer Invasion, Ministry of Education, China
    Search for more papers by this author
  • Jun-Jie Zhu,

    1. Liver Cancer Institute & Zhongshan Hospital, Institutes of Biomedical Science, Fudan University, Shanghai, China; Key Laboratory of Carcinogenesis & Cancer Invasion, Ministry of Education, China
    Search for more papers by this author
  • Hai-Jun Zhou,

    1. Liver Cancer Institute & Zhongshan Hospital, Institutes of Biomedical Science, Fudan University, Shanghai, China; Key Laboratory of Carcinogenesis & Cancer Invasion, Ministry of Education, China
    Search for more papers by this author
  • Hai-Jing Sun,

    1. Liver Cancer Institute & Zhongshan Hospital, Institutes of Biomedical Science, Fudan University, Shanghai, China; Key Laboratory of Carcinogenesis & Cancer Invasion, Ministry of Education, China
    Search for more papers by this author
  • Guan Wang,

    1. Liver Cancer Institute & Zhongshan Hospital, Institutes of Biomedical Science, Fudan University, Shanghai, China; Key Laboratory of Carcinogenesis & Cancer Invasion, Ministry of Education, China
    Search for more papers by this author
  • Xiao-Fei Zhang,

    1. Liver Cancer Institute & Zhongshan Hospital, Institutes of Biomedical Science, Fudan University, Shanghai, China; Key Laboratory of Carcinogenesis & Cancer Invasion, Ministry of Education, China
    Search for more papers by this author
  • Yu-Hua Xue,

    1. Liver Cancer Institute & Zhongshan Hospital, Institutes of Biomedical Science, Fudan University, Shanghai, China; Key Laboratory of Carcinogenesis & Cancer Invasion, Ministry of Education, China
    Search for more papers by this author
  • Hu-Liang Jia,

    1. Liver Cancer Institute & Zhongshan Hospital, Institutes of Biomedical Science, Fudan University, Shanghai, China; Key Laboratory of Carcinogenesis & Cancer Invasion, Ministry of Education, China
    Search for more papers by this author
  • Qing-Hai Ye,

    1. Liver Cancer Institute & Zhongshan Hospital, Institutes of Biomedical Science, Fudan University, Shanghai, China; Key Laboratory of Carcinogenesis & Cancer Invasion, Ministry of Education, China
    Search for more papers by this author
  • Lun-Xiu Qin

    Corresponding author
    1. Liver Cancer Institute & Zhongshan Hospital, Institutes of Biomedical Science, Fudan University, Shanghai, China; Key Laboratory of Carcinogenesis & Cancer Invasion, Ministry of Education, China
    Search for more papers by this author

To whom correspondence should be addressed.
E-mail: qin.lunxiu@zs-hospital.sh.cn

Abstract

Our previous study has identified HTPAP as a novel metastasis suppressor from chromosome 8p which is often deleted in metastatic HCC. We sought to further evaluate the expression levels of transcript variants of HTPAP (HTPAP-1, HTPAP-2 and HTPAP-3) in 67 HCC tumor tissues and 11 normal liver tissues by RT-PCR with specific TaqMan probes and primer sets, and explore their association with HCC metastasis and survival. We found that the expression levels of three HTPAP transcript variants were quite different in HCCs. Only HTPAP-1 was found to be significantly associated with HCC metastasis (P = 0.00053), overall survival (P = 0.0023) and time to recurrence (P = 0.010) of HCC. Patients with a lower expression of HTPAP-1 were inclined to accompany intrahepatic metastases and tumor thrombi (P < 0.05) and had a poor prognosis. In vitro, three fusion pEGFP-N1 vectors encoding HTPAP-1, HTPAP-2 and HTPAP-3 were introduced into HCC cells respectively to track HTPAPs’ expressions and identify their function. We found overexpression of HTPAP-1 conferred HCC cells reduced ability of invasion without significant impact on cell proliferation, and also displayed a distinct cell location on cell membrane and in cytoplasm, which were different from two other variants. Consequently, HTPAP-1 may be the transcript of HTPAP to exhibit a suppressive role on HCC metastasis, and can be a prognostic marker for HCC. (Cancer Sci 2011; 102: 583–590)

Ancillary